What Has Been Driving G1 Therapeutics Inc. (GTHX) Stock Price Down?
G1 Therapeutics, Inc. (GTHX), is a commercial-stage biopharmaceutical company specializing in the discovery, development, and delivery of modern therapies, introduced two scientific posters at the International Society for Pharmacoeconomics and Outcomes Research focusing on the approximate economic repercussions of treating myelosuppression along with patients with high-stage small cell lung cancer. At last check-in after-market trading, […]
